Glucagon-Like Peptide-1 Receptor Agonist Use is Not Associated With Increased Complications After Total Knee Arthroplasty in Patients With Type-2 Diabetes
This study found that GLP-1 agonist use was not associated with increased medical or surgical complication rates in patients with diabetes undergoing TKA and was associated with lower rates of extended hospital stays after surgery. Given the potential for increased glycemic control and weight loss in patients using GLP-1 agonists, more data are needed to delineate the potential role of GLP-1 agonists in preoperative optimization of patients with diabetes prior to joint arthroplasty to minimize postoperative complications.
Authors
- Brian T. Muffly (ORCID: https://orcid.org/0000-0001-6139-1058)
- J Scott Holmes (ORCID: https://orcid.org/0000-0002-5816-1021)
- Kevin Heo (ORCID: https://orcid.org/0009-0000-0865-8390)
- Greg A. Erens (ORCID: https://orcid.org/0000-0002-0577-203X)
- Jacob M. Wilson (ORCID: https://orcid.org/0000-0002-5044-7084)
- Andrew Fuqua (ORCID: https://orcid.org/0000-0003-1067-612X)
- Rahul Goel (ORCID: https://orcid.org/0000-0002-0515-0361)
- Ajay Premkumar (ORCID: https://orcid.org/0000-0003-1080-8655)
Institutions
- Hospital for Special Surgery (US)
- Emory University (US)
- Duke University (US)
Publication Details
- Journal
- Arthroplasty Today
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1016/j.artd.2024.101506
- Citations
- 18
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 6.44